AbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive Dataset

New MappingHepC.com website provides HCV community an easily accessible source of chronic HCV epidemiology data NORTH CHICAGO, Ill., Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutica... Biopharmaceuticals, Diagnostics AbbVie, Hepatitis C
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news